Nudifloside B exhibits significant anti-inflammatory properties, making it a candidate for development in treatments targeting chronic inflammatory diseases. It has been shown to inhibit key pro-inflammatory cytokines such as TNF-α and IL-6 in cellular models, suggesting potential use in autoimmune conditions like rheumatoid arthritis or inflammatory bowel disease. Additionally, studies indicate neuroprotective effects, where Nudifloside B reduces oxidative stress and neuronal damage in vitro, pointing to possible applications in neurodegenerative disorders such as Alzheimer’s disease. Its ability to modulate signaling pathways involved in cell survival and apoptosis also supports exploration in oncology, particularly as an adjuvant to enhance the efficacy of conventional chemotherapeutic agents. Due to its natural origin and observed low cytotoxicity in normal cells, it is being considered for nutraceutical and cosmeceutical formulations aimed at anti-aging and skin protection.